|
|
| Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help |
|
Health Affairs, 25, no. 5 (2006):
1347-1352
doi: 10.1377/hlthaff.25.5.1347 © 2006 by Project HOPE |
|
 |
|||||||||||||
| ||||||||||||||||||||
Managing Biotechnology In A Network-Model Health Plan: A U.S. Private Payer Perspective
Watkins
et al.
Health Affairs
25, no. 5 (2006): 1347
Online Exhibit
This Data Supplement consists of supplemental material that, because of space constraints, was not included with the published paper by John B. Watkins and colleagues, "Managing Biotechnology in a Network-Model Health Plan: A U.S. Private Payer Perspective."
DISCLAIMER: This material is presented to supplement the published paper. Although it was part of the manuscript that was subjected to the scrutiny of external reviewers, it has not been edited or formatted by the editors of Health Affairs; the authors are solely responsible for any errors herein.
Files in this Data Supplement:
| Home | | | Current Issue | | | Archives | | | Topic Collections | | | Search | | | Blog | | | Subscribe | | | Contact Us | | | Help |
|
© 2001-2009 Project
HOPE–The People-to-People Organization |
||||||||||||||||